LOS ANGELES–(BUSINESS WIRE)–For decades, the treatment for a young child with a broken femur has been the same: a surgically placed spica cast, commonly known as a body cast. But now, thanks to a new study led by Children’s Hospital Los Angeles, the days of casting these injuries may soon be over. The study, led … [Read more…]
Opzelura is the first and only FDA-approved product for repigmentation in nonsegmental vitiligo Phase 3 data supporting the approval show treatment with Opzelura resulted in improvements in facial and total body repigmentation Fifty-two week data demonstrate continued improvements in repigmentation with longer duration of treatment Investor conference call and webcast scheduled for July 19, 2022, … [Read more…]
GUILFORD, Conn.–(BUSINESS WIRE)–Jul. 18, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first next generation single molecule protein sequencing, today announced that it will report financial results for the second quarter 2022 after market close on Monday, August 8, 2022. Company management will host a conference call to … [Read more…]
NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the third quarter of 2022 of $1.13 per share on the company’s common stock. The dividend is payable on September 6, 2022 to shareholders of record at the close of business on August 23, 2022. The … [Read more…]
Expansion Will Grow Service Area to More Than 70 Countries Throughout Europe, the Middle East and Africa BURLINGTON, N.C.–(BUSINESS WIRE)–Labcorp® (NYSE: LH), a leading global life sciences company, today announced an expansion of its automated clinical trial kit production line in Mechelen, Belgium. Once completed, expansion will allow for clinical trial test kits to be … [Read more…]
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the second quarter of 2022 on Thursday, July 28, 2022, following the close of the market. The company will discuss these results in a conference call scheduled for 3 … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for trofinetide for the treatment of Rett syndrome in adults and pediatric patients two years of age and older. “This is an important step forward for members of … [Read more…]
LAVAL, Quebec–(BUSINESS WIRE)–BELLUS Health Inc. (NASDAQ: BLU)(TSX: BLU) (the “Company” or “BELLUS Health”) announced today that it has completed its previously-announced underwritten public offering in Canada and the United States (the “Offering”) of 16,540,541 common shares at a price to the public of US$9.25 per common share. The total gross proceeds to the Company were … [Read more…]
Health care industry veteran assumes new role to advance the network’s strategic and continued growth MULLICA HILL, N.J.–(BUSINESS WIRE)–Inspira Health today announced the appointment of Tony S. Reed, M.D., to Senior Vice President, Chief Quality and Safety Officer, effective August 1. In this role, Reed will focus on executing and expanding Inspira’s role as a … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Medical Footwear Global Market Report 2022, By Sales Channel, By Application, By End User Sex” report has been added to ResearchAndMarkets.com’s offering. The global medical footwear market is expected to grow from $8.40 billion in 2021 to $8.97 billion in 2022 at a compound annual growth rate (CAGR) of 6.80%. The market is … [Read more…]
